TY - JOUR
T1 - 18F-DCFPyL Uptake in an Incidentally Detected Follicular Lymphoma by PET/CT Performed for Biochemically Recurrent Prostate Cancer
AU - Meijer, Dennie
AU - Wondergem, Maurits
AU - Knol, Remco J. J.
AU - Broos, Wouter A. M.
AU - van der Zant, Friso M.
PY - 2020/2/1
Y1 - 2020/2/1
N2 - A 75-year-old man, treated with curative intent for histopathologically proven prostate cancer (initial prostate-specific antigen, 27 ng/mL; Gleason 4 + 5 = 9) through external beam radiation therapy in 2010 in combination with 3 years of androgen deprivation therapy (leuprorelin), underwent
18F-DCFPyL PET/CT for biochemical recurrence with a prostate-specific antigen of 4.1 ng/mL in February 2019. Multiple pelvic and some para-aortic lymph nodes showed highly increased
18F-DCFPyL uptake, suspicious for metastases. Incidentally, a solid mesenteric mass and mesenteric lymph nodes with moderately increased
18F-DCFPyL uptake were found. Upon histopathological evaluation, this proved to be a low-grade follicular lymphoma.
AB - A 75-year-old man, treated with curative intent for histopathologically proven prostate cancer (initial prostate-specific antigen, 27 ng/mL; Gleason 4 + 5 = 9) through external beam radiation therapy in 2010 in combination with 3 years of androgen deprivation therapy (leuprorelin), underwent
18F-DCFPyL PET/CT for biochemical recurrence with a prostate-specific antigen of 4.1 ng/mL in February 2019. Multiple pelvic and some para-aortic lymph nodes showed highly increased
18F-DCFPyL uptake, suspicious for metastases. Incidentally, a solid mesenteric mass and mesenteric lymph nodes with moderately increased
18F-DCFPyL uptake were found. Upon histopathological evaluation, this proved to be a low-grade follicular lymphoma.
KW - F-DCFPyL PET/CT
KW - follicular lymphoma
KW - prostate cancer
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85077401631&origin=inward
UR - https://www.ncbi.nlm.nih.gov/pubmed/31361646
U2 - 10.1097/RLU.0000000000002738
DO - 10.1097/RLU.0000000000002738
M3 - Article
C2 - 31361646
VL - 45
SP - e96-e97
JO - Clinical Nuclear Medicine
JF - Clinical Nuclear Medicine
SN - 0363-9762
IS - 2
ER -